February 21, 2013
Journal Article

Liver-derived systemic factors drive ß-cell hyperplasia in insulin resistant states

Abstract

Integrative organ cross-talk regulates key aspects of energy homeostasis and its dysregulation may underlie metabolic disorders such as obesity and diabetes. To test the hypothesis that cross-talk between the liver and pancreatic islets modulates ß-cell growth in response to insulin resistance, we used the Liver-specific Insulin Receptor Knockout (LIRKO) mouse, a unique model that exhibits dramatic islet hyperplasia. Using complementary in vivo parabiosis and transplantation assays, and in vitro islet culture approaches, we demonstrate that humoral, non-neural, non-cell autonomous factor(s) induce ß-cell proliferation in LIRKO mice. Furthermore, we report that a hepatocyte-derived factor(s) stimulates mouse and human ß-cell proliferation in ex vivo assays, independent of ambient glucose and insulin levels. These data implicate the liver as a critical source of ß-cell growth factors in insulin resistant states.

Revised: August 6, 2014 | Published: February 21, 2013

Citation

El Ouaamari A., D. Kawamori, E. Dirice, C. Liew, J.L. Shadrach, J. Hu, and H. Katsuta, et al. 2013. Liver-derived systemic factors drive ß-cell hyperplasia in insulin resistant states. Cell Reports 3, no. 2:401-410. PNNL-SA-93433. doi:10.1016/j.celrep.2013.01.007